Status:
NOT_YET_RECRUITING
Adaptation of the ECCCLORE Program for Patients With Addictive and Traumatic Problems
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
PTSD
Addiction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Complex posttraumatic stress disorder (cPTSD) is characterized by chronic and pervasive disruptions in emotion regulation, identity, and relationships following prolonged or multiple exposures to trau...
Eligibility Criteria
Inclusion
- Patients with one or more addictions
- Score greater than or equal to 27 on the ASSIST questionnaire.
- Diagnosis of PTSD and/or CPTSD assessed using the ITQ scale.
- Ability to understand, write, and read French
- The patient must have given their free and informed consent
- The patient must be a member or beneficiary of a health insurance plan
Exclusion
- The subject is participating in an interventional study involving a drug or medical device or a Category 1 study within 3 months prior to inclusion
- The patient is under safeguard of justice or state guardianship
- Patients with a psychotic disorder
- Patients with severe cognitive impairment (MoCA \< 10)
- Patients experiencing a manic or hypomanic episode
- Patients experiencing a major depressive episode
- Patients participating in an interventional study involving a drug or medical device or a Category 1 RIPH within 3 months prior to inclusion
- Pregnant, parturient, or breastfeeding woman
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07193914
Start Date
September 1 2025
End Date
March 1 2027
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, Nîmes, France, 30029